New York, New York, United States Related Funds
| Fund Name | Location |
| AriMed Advisors | China, Shanghai |
| E&Company | - |
| Greylock Partners | California, Menlo Park, United States |
| Growceanu Angel Investment | - |
| KAIST Venture | - |
| Laconia Ventures | New York, New York, United States |
| National Health Forecast (PSN) | - |
| Not Boring | - |
| Partners Resolute | New York, New York, United States |
| Revival Healthcare Capital | Austin, Texas, United States |
| South Dakota Equity Partners | Sioux Falls, South Dakota, United States |
| Terada Warehouse | Chiyoda, Japan |
| Upstart Life Ventures | Salt Lake City, United States, Utah |
| Venture Builders | Incline Village, Nevada, United States |
| Verde Company BVBA | - |
| Vereeni Investments | - |
| Wanxiang International Investment | China, Hangzhou, Zhejiang |
| WapInvest | - |
| WPMC | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Scorpion Therapeutics | $150M | 16 Jul 2024 | Boston, Massachusetts, United States | ||
Cellares | $255M | 23 Aug 2023 | South San Francisco, California, United States | ||
NextRNA Therapeutics | $46M | 01 Mar 2022 | Cambridge, Massachusetts, United States | ||
Disc Medicine | $90M | 02 Sep 2021 | Cambridge, Massachusetts, United States | ||
Shape Therapeutics | $112M | 15 Jul 2021 | Seattle, Washington, United States | ||
Finch Therapeutics | $53M | 21 Aug 2019 | Massachusetts, United States | ||
Finch Therapeutics | $36M | 01 Mar 2018 | Massachusetts, United States |
– Circle, a global financial technology firm based in Boston, raised $440m in a series E funding.
– The round was led by Fidelity Management and Research Company, Marshall Wace, Willett Advisors, Intersection Fintech Ventures, Atlas Merchant Capital, Digital Currency Group, FTX, Breyer Capital, Valor Capital Group, Pillar VC as well as Michael J. Price and Friends.
– The new investment will be used for continued growth, organizational development and market expansion opportunities.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Scorpion Therapeutics | $150M | 16 Jul 2024 | Boston, Massachusetts, United States | ||
Cellares | $255M | 23 Aug 2023 | South San Francisco, California, United States | ||
NextRNA Therapeutics | $46M | 01 Mar 2022 | Cambridge, Massachusetts, United States | ||
Disc Medicine | $90M | 02 Sep 2021 | Cambridge, Massachusetts, United States | ||
Shape Therapeutics | $112M | 15 Jul 2021 | Seattle, Washington, United States | ||
Finch Therapeutics | $53M | 21 Aug 2019 | Massachusetts, United States | ||
Finch Therapeutics | $36M | 01 Mar 2018 | Massachusetts, United States |
